In consistent with their results, the girl with MKRN3 mutation in our present study presented with typical rapidly progressive clinical features of CPP, including the menstrual onset after the breast development only 2 months, the advanced bone age, and the accelerated growth velocity. This evidence concerns the gene MKRN3 and central precocious puberty.